Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Acro Biomedical (ACBM) Return on Equity (2017 - 2025)

Acro Biomedical has reported Return on Equity over the past 9 years, most recently at 0.25% for Q4 2025.

  • Quarterly results put Return on Equity at 0.25% for Q4 2025, up 10.0% from a year ago — trailing twelve months through Dec 2025 was 0.25% (up 10.0% YoY), and the annual figure for FY2025 was 0.3%, up 14.0%.
  • Return on Equity for Q4 2025 was 0.25% at Acro Biomedical, down from 0.41% in the prior quarter.
  • Over the last five years, Return on Equity for ACBM hit a ceiling of 35.47% in Q4 2023 and a floor of 254.38% in Q3 2023.
  • Median Return on Equity over the past 5 years was 0.98% (2021), compared with a mean of 17.69%.
  • Biggest five-year swings in Return on Equity: tumbled -23618bps in 2023 and later skyrocketed 25455bps in 2024.
  • Acro Biomedical's Return on Equity stood at 2.67% in 2021, then tumbled by -1115bps to 32.44% in 2022, then soared by 209bps to 35.47% in 2023, then crashed by -100bps to 0.15% in 2024, then surged by 69bps to 0.25% in 2025.
  • The last three reported values for Return on Equity were 0.25% (Q4 2025), 0.41% (Q3 2025), and 0.15% (Q2 2025) per Business Quant data.